Thomas Grunwald
Inventor
Stats
- 8 US patents issued
- 24 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 8 US Patents Issued
- 24 US Applications Filed
- 57 Total Citation Count
- Jul 8, 2022 Most Recent Filing
- Sep 10, 1993 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
PEVION BIOTECH AG | 1
| 2007
|
KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAET MUENCHEN | 1
| 2013
|
Ruhr-Universitaet Bochum | 1
| 2007
|
HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUR GESUNDHEIT UND UMWELT (GMBH) | 1
| 2013
|
KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN | 2
1 | 2013
2014 |
PLS-Design GmbH | 2
4 2 2 2 1 4 1 1 1 | 2005
2006 2007 2009 2010 2012 2013 2014 2015 2016 |
HELMHOLTZ ZENTRUM MUNCHEN FORSCHUNGSZENTRUM FUR GESUNDHEIT UND UMWELT GMBH | 1
2 1 | 2012
2013 2014 |
GEORGETOWN UNIVERSITY | 1
| 1993
|
HELMHOLTZ ZENTRUM MUENCHEN FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH | 1
| 2015
|
RINA NETZWERK RNA TECHNOLOGIEN GMBH | 1
1 | 2006
2013 |
Inventor Addresses
Address | Duration |
---|---|
Bochum, DE | Feb 12, 13 - Feb 12, 13 |
Hamburg, DE | Feb 03, 98 - Sep 01, 22 |
Leipzig, DE | Dec 10, 20 - Feb 20, 25 |
Technology Profile
Technology | Matters | |
---|---|---|
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 21 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 3 |
C07H: | SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS | 5 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2025/0057,802 | 2025 | BROAD-SPECTRUM ANTIVIRAL DRUGS | 0 |
11946048 | 2024 | Non-human papillomaviruses for gene delivery in vitro and in vivo | 0 |
2022/0273,791 | 2022 | SELECTIVE LOCAL INHIBITION OF TNFR1-MEDIATED FUNCTIONS AT THE SITE OF ANTIGEN/ALLERGEN PRESENTATION | 0 |
11065330 | 2021 | Induction of antigen-specific tolerance by peripheral phagocytosis | 0 |
2020/0385,718 | 2020 | Non-human papillomaviruses for gene delivery in vitro and in vivo | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.